$109.48
3.493.29%
At close: -
$109.48
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Ligand Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:LGND | Benzinga
Ligand Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS
$1.330
Quarterly Revenue
$45.33M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$181.49M
Analyze the earnings history of Ligand Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals | $1.40 | — | — | — | $41.53M | — | — | — | 08/05/2025 | Get Alert |
| LGND | Ligand Pharmaceuticals | $3.84 | $1.21 | $1.33 | 9.92% | $30.98M | $37.84M | $45.33M | 19.80% | 05/08/2025 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.38 | $1.19 | $1.27 | 6.72% | $28.10M | $39.03M | $42.81M | 9.69% | 02/27/2025 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.02 | $1.35 | $1.84 | 36.30% | $32.87M | $40.65M | $51.81M | 27.46% | 11/07/2024 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.42 | $0.98 | $1.40 | 42.86% | $26.37M | $31.90M | $41.53M | 30.19% | 08/06/2024 | Get Alert |
| LGND | Ligand Pharmaceuticals | $2.28 | $0.78 | $3.84 | 392.31% | $43.98M | $27.92M | $30.98M | 10.95% | 05/07/2024 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.36 | $0.66 | $1.38 | 109.09% | $50.38M | $25.72M | $28.10M | 9.26% | 02/27/2024 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.60 | $0.61 | $1.02 | 67.21% | $59.22M | $27.19M | $32.87M | 20.88% | 11/08/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.03 | $0.64 | $1.42 | 121.88% | $57.42M | $25.73M | $26.37M | 2.47% | 08/08/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.76 | $0.89 | $2.28 | 156.18% | $45.69M | $34.04M | $43.98M | 29.20% | 05/04/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.80 | $1.19 | $1.36 | 14.29% | $72.47M | $46.64M | $50.38M | 8.02% | 02/22/2023 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.58 | $0.43 | $1.31 | 204.65% | $64.83M | $38.28M | $66.09M | 72.64% | 11/07/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.63 | $0.43 | $1.03 | 139.53% | $84.67M | $37.73M | $57.42M | 52.18% | 08/08/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.41 | $0.66 | $0.76 | 15.15% | $55.15M | $34.21M | $45.69M | 33.57% | 05/04/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.62 | $1.37 | $1.80 | 31.39% | $69.99M | $65.32M | $72.47M | 10.95% | 02/17/2022 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.04 | $1.04 | $1.58 | 51.92% | $41.85M | $55.65M | $64.83M | 16.50% | 11/09/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $1.00 | $1.34 | $1.63 | 21.64% | $41.42M | $70.41M | $84.67M | 20.26% | 07/29/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.89 | $1.12 | $1.41 | 25.89% | $33.16M | $62.85M | $55.15M | -12.25% | 05/03/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.71 | $0.99 | $1.62 | 63.64% | $27.00M | $54.09M | $69.99M | 29.40% | 02/03/2021 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.49 | $0.98 | $1.04 | 6.12% | $24.81M | $44.36M | $41.85M | -5.66% | 10/30/2020 | Get Alert |
| LGND | Ligand Pharmaceuticals | $0.68 | $0.76 | $1.00 | 31.58% | $24.99M | $29.96M | $41.42M | 38.25% | 08/03/2020 | Get Alert |
Ligand Pharmaceuticals (LGND) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $1.33 | $1.21 | 9.92 % |
| Q4 | 2025-02-27 | $1.27 | $1.19 | 6.72 % |
| Q3 | 2024-11-07 | $1.84 | $1.35 | 36.3 % |
| Q2 | 2024-08-06 | $1.40 | $0.98 | 42.9 % |
Ligand Pharmaceuticals (LGND) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $45.33M | $37.84M | 19.8 % |
| Q4 | 2025-02-27 | $42.81M | $39.03M | 9.69 % |
| Q3 | 2024-11-07 | $51.81M | $40.65M | 27.5 % |
| Q2 | 2024-08-06 | $41.53M | $31.90M | 30.2 % |
FAQ
When is Ligand Pharmaceuticals (NASDAQ:LGND) reporting earnings?
Ligand Pharmaceuticals (LGND) is scheduled to report earnings on August 5, 2025. The last reported earnings were for reported on May 8, 2025 for Q1.
What were the latest earnings per share (EPS) for Ligand Pharmaceuticals (NASDAQ:LGND)?
The Actual EPS was $1.33, which beat the estimate of $1.21.
What were Ligand Pharmaceuticals’s (NASDAQ:LGND) revenues?
The Actual Revenue was $45.3M, which beat the estimate of $37.8M.
Browse earnings estimates, EPS, and revenue on all stocks.
